NCT04497961 2025-09-11A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or LenalidomideMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting95 enrolled
NCT03654105 2024-03-07SMILEFondazione IRCCS Istituto Nazionale dei Tumori, MilanoPhase 2 Active not recruiting2,000 enrolled